Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jul;38(7):1317-25.
doi: 10.3899/jrheum.100956. Epub 2011 Jun 17.

Late-age onset systemic sclerosis

Affiliations
Comparative Study

Late-age onset systemic sclerosis

Rebecca L Manno et al. J Rheumatol. 2011 Jul.

Abstract

Objective: Although patients who develop systemic sclerosis (SSc) later in life (≥ 65 yrs) may express the entire clinical spectrum of disease, we hypothesize that patients with late-age onset SSc incur a different risk for specific organ manifestations of disease compared to those with early-age onset SSc.

Methods: In total, 2300 patients with SSc were evaluated between 1990 and 2009 and reviewed from a university-based scleroderma center cohort. Demographic profile, SSc subtype, autoantibody status, Medsger severity scores, pulmonary function tests, echocardiography, and right heart catheterization measures were compared between late-age onset vs younger-age onset patients with SSc.

Results: Overall, 2084 patients (91%) developed SSc prior to age 65, while 216 (9%) were ≥ 65 years. Late-age onset patients had a significantly higher proportion of anticentromere antibodies (42% vs 27%; p = 0.001) compared to early-age onset patients. Risk of pulmonary hypertension (OR 1.76, 95% CI 1.00, 3.12), muscle weakness (OR 1.85, 95% CI 1.30, 1.64), renal impairment (OR 2.83, 95% CI 1.98, 4.04), and cardiac disease (OR 2.69, 95% CI 1.92, 3.78) was greater among those with late-age onset SSc; although risk of digital ischemia (OR 0.64, 95% CI 0.47, 0.86) was reduced. The cumulative incidence of pulmonary hypertension at 5 years was greater among those with late-age onset SSc (9%) compared to those with early-age onset SSc (2.7%; log-rank, p < 0.001).

Conclusion: These findings suggest that older patients with SSc are at greater risk for pulmonary hypertension, renal impairment, cardiac disease, and muscle weakness. Awareness of the distinct risk for specific organ manifestations in SSc, in particular pulmonary hypertension, should guide the care of patients with SSc whose disease begins after age 65.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age of scleroderma onset as defined by age of first non-Raynaud's scleroderma symptom among 2300 patients evaluated at the Johns Hopkins Scleroderma Center from 1990–2009
Figure 2a
Figure 2a
Cumulative incidence of pulmonary hypertension, defined by right heart catheterization, by age of scleroderma onset among patients with two or more visits to the Johns Hopkins Scleroderma Center. P<0.001
Figure 2b
Figure 2b
Cumulative incidence of pulmonary hypertension, defined by right heart catheterization or echocardiogram, by age of scleroderma onset among patients with two or more visits to the Johns Hopkins Scleroderma Center. P<0.001

References

    1. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis. 2007 Jul;66(7):940–4. - PMC - PubMed
    1. Steen VD, Medsger TA., Jr. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am. 1990 Feb;16(1):1–10. - PubMed
    1. Mayes MD, Lacey JV, Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003 Aug;48(8):2246–55. - PubMed
    1. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA., Jr. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum. 1997 Mar;40(3):441–5. - PubMed
    1. Medsger TA, Jr, Masi AT. Epidemiology of systemic sclerosis (scleroderma) Ann Intern Med. 1971 May;74(5):714–21. - PubMed

Publication types

MeSH terms